参考文献/References:
[1] Nolan MT,Russell DJ,Marwick TH.Long-term risk of heart failure and myocardial dysfunction after thoracic radiotherapy:a systematic review[J].Can J Cardiol,2016,32(7):908-920.
[2] Jaworski C,Mariani JA,Wheeler G,et al. Cardiac complications of thoracic irradiation[J]. J Am Coll Cardiol,2013,61(23):2319-2328.
[3] 中华人民共和国卫生部.放射性心脏病损伤诊断[J]. 中国医药科学,2012,2(7):5-6.
[4] Ezaz G,Long JB,Gross CP,et al. Risk prediction model for heart failure and cardiomyopathy after adjuvant trastuzumab therapy for breast cancer[J]. J Am Heart Assoc,2014,3(1):e000472.
[5] Zhu Q,Kirova YM,Cao L,et al. Cardiotoxicity associated with radiotherapy in breast cancer:a question-based review with current literatures[J]. Cancer Treat Rev,2018,68:9 -15.
[6] Schmitz KH,Prosnitz RG,Schwartz AL,et al. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors[J]. Cancer,2012,118( 8 suppl):2270-2276.
[7] Yusuf SW,Hassan SA,Mouhayar E,et al. Pericardial disease :a clinical review[J]. Expert Rev Cardiovasc Ther,2016,14(4):525-539.
[8] Madan R,Benson R,Sharma DN,et al. Radiation induced heart disease:pathogenesis, management and review literature[J]. J Egypt Natl Canc Inst,2015,27(4):187-193.
[9] Cuomo JR,Sharma GK,Conger PD,et al. Novel concepts in radiation-induced cardiovascular disease[J]. World J Cardiol,2016,8(9):504-519.
[10] Avgerinos D,Rabitnokov Y,Worku B,et al. Fifteen-year experience and outcomes of pericardiectomy for constrictive pericarditis[J]. J Card Surg,2014,29(4):434-438.
[11]Bertog SC,Thambidorai SK,Parakh K,et al. Constrictive pericarditis:etiology and cause-specific survival after pericardiectomy[J]. J Am Coll Cardiol,2004,43(8):1445-1452.
[12] Saxena P,Joyce LD,Daly RC,et al. Cardiac transplantation for radiation-induced cardiomyopathy:the Mayo Clinic experience[J]. Ann Thorac Surg,2014,98(6):2115-2121.
[13] Zeng YC,Chi F,Xing R,et al. Sestrin2 protects the myocardium against radiation-induced damage[J]. Radiat Environ Biophys,2016,55(2):195-202.
[14] Kursova LV,Konoplyannikov AG,K al’sina SSh,et al. Allogenic cardiomyoblasts raised from human mesenchymal stem cells in the therapy of radiation cardiomyopathy and pericarditis: case report[J]. Bull Exp Biol Med,2014,157(1):143-145.
[15] Cutter DJ,Schaapveld M,Darby SC,et al. Risk of valvular heart disease after treatment for Hodgkin lymphoma[J]. J Natl Cancer Inst,2015,107(4).pii:djv008-djv008.
[16] Dijos M,Reynaud A,Leroux L,et al. Efficacy and follow-up of transcatheter aortic valve implantation in patients with radiation-induced aortic stenosis[J].Open Heart,2015,2(1):e000252.
[17] Cuomo JR,Javaheri SP,Sharma GK,et al. How to prevent and manage radiation-induced coronary artery disease[J]. Heart,2018,104(20):1647-1653.
[18] Zhu Q,Kirova YM,Cao L,et al. Cardiotoxicity associated with radiotherapy in breast cancer:a question-based review with current literatures[J]. Cancer Treat Rev,2018,68:9.
[19] Hoving S,Heeneman S,Gijbels MJ,et al. Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin,clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice[J]. Radiother Oncol,2011,101(1):100-108.
[20] Kang J,Kim YC,Park JJ,et al. Increased epicardial adipose tissue thickness is a predictor of new-onset diabetes mellitus in patients with coronary artery disease treated with high-intensity statins[J]. Cardiovasc Diabetol,2018,17(1):10.
[21] Ziegler V,Henninger C,Simiantonakis I,et al. Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiation[J]. Cell Death Dis,2017,8(8):e2978.
[22] Marlatt KL,Steinberger J,Rudser KD,et al. The effect of atorvastatin on vascular function and structure in young adult survivors of childhood cancer:a randomized, placebo-controlled pilot clinical trial[J]. J Adolesc Young Adult Oncol,2019,8(4):442-450.
[23] Doi H,Matsumoto S,Odawara S,et al. Pravastatin reduces radiation-induced damage in normal tissues [J].Exp Ther Med,2017,13(5):1765-1772.
[24] van der Veen SJ,Ghobadi G,de Boer RA,et al. ACE inhibition attenuates radiation-induced cardiopulmonary damage[J]. Radiother Oncol,2015,114(1):96-103.
[25] 吴荣,马天馨,曾越灿. 血管紧张素Ⅱ1型受体拮抗剂在大鼠放射性心脏损伤中保护作用的研究[J]. 中国医科大学学报,2015,44(1):20-26.
[26] Alite F,Balasubramanian N,Adams W,et al. Decreased risk of radiation pneumonitis with coincident concurrent use of angiotensin-converting enzyme inhibitors in patients receiving lung stereotactic body radiation therapy[J]. Am J Clin Oncol,2018,41(6):576-580.
[27] Pakala R,Dilcher C,Baffour R,et al. Peroxisome proliferator-activated receptor gamma ligand pioglitazone alters neointimal composition in a balloon-denuded and radiated hypercholesterolemic rabbit[J]. J Cardiovasc Pharmacol,2006,48(6):299-305.
[28] Cramer CK,Alphonse-Sullivan N,Isom S,et al. Safety of pioglitazone during and after radiation therapy in patients with brain tumors:a phase I clinical trial[J]. J Cancer Res Clin Oncol, 2019,145(2):337-344.
[29] Kumar S,Sharma S,Vasudeva N. Review on antioxidants and evaluation procedures[J]. Chin J Integr Med, 2017,Oct 6.DOI:10.1007/s11655-017-2414-2[Epub ahead of print].
[30] Liu H,Xiong M,Xia YF,et al. Studies on pentoxifylline and tocopherol combination for radiation-induced heart disease in rats[J]. Int J Radiat Oncol Biol Phys,2009,73(5):1552-1559.
[31] Zamorano JL,Lancellotti P,Rodriguez Mu?oz D,et al. 2016 ESC position paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC committee for practice guidelines:the task force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology(ESC)[J].Eur Heart J,2016,37(36):2768-2801.
相似文献/References:
[1]白春兰,张军.正五聚蛋白-3:新型心血管病炎性标志物[J].心血管病学进展,2016,(1):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
BAI Chunlan,ZHANG Jun.Pentraxin-3: A Novel Inflammation Biomarker for Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(5):87.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.023]
[2]任茂佳,贺文帅,张琪,等.围绝经期对心血管疾病相关危险因素的影响[J].心血管病学进展,2019,(6):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
REN Maojia,HE Wenshuai,ZHANG Qi,et al.Effects of Perimenopause on Cardiovascular Risk Factors[J].Advances in Cardiovascular Diseases,2019,(5):911.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.018]
[3]尹琳 黄从新.JP2蛋白和心血管疾病的研究进展[J].心血管病学进展,2019,(7):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
YIN Lin HUANG Congxin.Research Progress of JP2 Protein and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1004.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.010]
[4]朱峰 汪汉 蔡琳.抗体与心血管疾病[J].心血管病学进展,2019,(7):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
ZHU FengWANG HanCAI Lin.Antibodies and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1007.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.011]
[5]邱明仙 王正龙 许官学.心肌肌球蛋白结合蛋白-C磷酸化与心血管疾病关系的研究进展[J].心血管病学进展,2019,(7):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
QIU MingxianWANG ZhenglongXU Guanxue.Research Progress of the Relationship Between Cardiac Myosin Binding Protein-C and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1015.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.013]
[6]姬楠楠 杨晓静 谢勇.单核细胞/高密度脂蛋白比值与心血管疾病的研究进展[J].心血管病学进展,2019,(7):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
JI Nannan YANG Xiaojing XIE Yong.Monocyte/High-density Lipoprotein Ratio and Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2019,(5):1019.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.014]
[7]渠海贤 李涛 程流泉.人工智能在心脏磁共振成像中的应用进展[J].心血管病学进展,2019,(5):659.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.001]
[8]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[9]张维 张恒 康品方.外泌体在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
Zhang WeiKang Pinfang.Exosome in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(5):818.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.038]
[10]韦莹 刘书旺 李蕾 崔鸣.生长分化因子-15在心房颤动中的研究进展[J].心血管病学进展,2019,(8):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]
WEI Ying,LIU Shuwang,LI Lei,et al.Growth Differentiation Factor-15 in Development of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2019,(5):1073.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.001]